Hong Kong vs Poland: The number of people with susceptibility test result for rifampicin
Hong Kong
2,181
in 2021
Poland
2,415
in 2021
Hong Kong rank
45th
Poland rank
43rd
The number of people with susceptibility test result for rifampicin over time
- Hong Kong
- Poland
How they compare
Poland currently reports 2,415 against 2,181 in Hong Kong, a difference of 234.
That makes Poland's figure about 1.1 times Hong Kong's.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Poland ahead.
Hong Kong ranks 45th and Poland ranks 43rd of 155 countries.
Poland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Hong Kong | Poland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2,387 | 3,229 | 841.67 | Poland |
| 2020s | 2,143 | 2,216 | 73 | Poland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Hong Kong or Poland?
- Poland, at 2,415 against 2,181 in Hong Kong as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Hong Kong and Poland?
- 234, with Poland ahead.
- How many years of comparable data are there for Hong Kong and Poland?
- 5 years are reported by both, from 2017 to 2021.
- How do Hong Kong and Poland rank globally for the number of people with susceptibility test result for rifampicin?
- Hong Kong ranks 45th and Poland ranks 43rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.